New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel
Coronavirus
WASHINGTON (AP) – A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19 pandemic . The Food and Drug Administration is evaluating Moderna's new shot , dubbed mFlusiva, for older Americans ahead of the winter flu season. Moderna is seeking full approval for the vaccine's use in people ages 50 to 64 – along with authorization for use in those 65
din zilele anterioare